BNET Industries

Pfizer Inc.

(PFE) is in the Pharma Industry

Market Cap:$149.2B

Last Fiscal Year Sales:$48.4B

Public
US

Dow Jones Description

Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.

Number of Employees 81,800

Contact Information

235 E 42nd St

New York, New York 10017-5755

www.pfizer.com

(212) 573-2323

Peer Companies

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Company News

Recent Events

Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update

12/04/09 - Joint Venture / Alliance - View Story
'IT boosts efficiency & innovation'

12/04/09 - Merger / Acquisition - View Story
Inspector General Saved Billions in Healthcare This Year

12/04/09 - Legal Settlement - View Story
Pfizer and B.C. launch $9M collaboration to tackle cancer

12/03/09 - Joint Venture / Alliance - View Story
Reportlinker Adds Growth Factors Blood And Tissue - A World Report

12/02/09 - Joint Venture / Alliance - View Story
Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa

12/02/09 - Joint Venture / Alliance - View Story
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M

12/02/09 - Joint Venture / Alliance - View Story
Roche's Merger Formula for Genentech

11/30/09 - Merger / Acquisition - View Story
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV

11/24/09 - Joint Venture / Alliance - View Story
Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...

11/27/09 - Financial Announcement - View Story
A 2nd Loss for Pfizer in Drug Suits

11/23/09 - Legal Settlement - View Story
Pfizer acquires stem cell therapies assets of Axordia

11/23/09 - Merger / Acquisition - View Story
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24

11/23/09 - Bond / Stock Rating - View Story
ImmunoVaccine signs exclusive licence deal with Pfizer

11/23/09 - Joint Venture / Alliance - View Story
Pfizer Animal Health selects Bader Rutter as agency of record

11/17/09 - Licensing / Contract - View Story
FDA panel backs Pfizer's anti-infection vaccine for kids

11/19/09 - Merger / Acquisition - View Story
Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started

11/16/09 - Joint Venture / Alliance - View Story
Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China

11/16/09 - Bond / Stock Rating - View Story

News & Analysis

pfizer inc. and reckitt benckiser plc. - All News and Analysis

Market sorts out the pretenders from contenders for Pfizer Consumer

- 2006-06-26

Earlier this month, Pfizer began entertaining bids for the purchase of its consumer health care division as the pharmaceutical giant considers selling the unit for more than $14 billion and using the cash to fund acquisitions in the biotechnology arena and perhaps a generic drug manufacturer. While the early...

Tags: Pfizer Inc., Reckitt Benckiser Plc.
Business News IN BRIEF: Reckitt lines up pounds 6bn Pfizer deal

- 2006-03-20

The consumer goods group Reckitt Benckiser is lining up financing for a pounds 6bn deal to buy the over-the-counter medicines arm of Pfizer, the maker of Sudafed and Listerine, it was reported over the weekend. The company has asked its broker CSFB to handle financing for the deal, which will...

Tags: Pfizer Inc., Reckitt Benckiser Plc.
Reckitt may swallow Pfizer's over-the-counter medicines

- 2006-02-19

Fresh from its pounds 1.9bn purchase of Boots' over-the-counter medicines business, Reckitt Benckiser may be angling for a much bigger fish, the $14bn (pounds 8bn) consumer healthcare business of Pfizer. The world's largest drug-maker announced earlier this month that it would explore "strategic alternatives", including a sale...

Tags: Pfizer Inc., Reckitt Benckiser Plc.